• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组功能基因组学和转录组学分析基因调控伏立诺他敏感性。

Genome-wide functional genomic and transcriptomic analyses for genes regulating sensitivity to vorinostat.

机构信息

Cancer Therapeutic Program, The Peter MacCallum Cancer Centre , St Andrews Place, East Melbourne, Victoria 3002, Australia.

Victorian Centre for Functional Genomics, The Peter MacCallum Cancer Centre , St Andrews Place, East Melbourne, Victoria 3002, Australia.

出版信息

Sci Data. 2014 Jul 8;1:140017. doi: 10.1038/sdata.2014.17. eCollection 2014.

DOI:10.1038/sdata.2014.17
PMID:25977774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4322586/
Abstract

Identification of mechanisms of resistance to histone deacetylase inhibitors, such as vorinostat, is important in order to utilise these anticancer compounds more efficiently in the clinic. Here, we present a dataset containing multiple tiers of stringent siRNA screening for genes that when knocked down conferred sensitivity to vorinostat-induced cell death. We also present data from a miRNA overexpression screen for miRNAs contributing to vorinostat sensitivity. Furthermore, we provide transcriptomic analysis using massively parallel sequencing upon knockdown of 14 validated vorinostat-resistance genes. These datasets are suitable for analysis of genes and miRNAs involved in cell death in the presence and absence of vorinostat as well as computational biology approaches to identify gene regulatory networks.

摘要

鉴定对组蛋白去乙酰化酶抑制剂(如伏立诺他)的耐药机制对于在临床上更有效地利用这些抗癌化合物非常重要。在这里,我们提供了一个数据集,其中包含多个层次的严格 siRNA 筛选,用于鉴定敲低后对伏立诺他诱导的细胞死亡敏感的基因。我们还提供了 miRNA 过表达筛选数据,用于鉴定促进伏立诺他敏感性的 miRNA。此外,我们还提供了在敲低 14 个已验证的伏立诺他耐药基因后使用大规模平行测序进行的转录组分析。这些数据集可用于分析在有或没有伏立诺他存在的情况下与细胞死亡相关的基因和 miRNA,以及用于识别基因调控网络的计算生物学方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/4322586/497c70899478/sdata201417-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/4322586/45e4ca255f81/sdata201417-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/4322586/d5825f26cc4b/sdata201417-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/4322586/497c70899478/sdata201417-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/4322586/45e4ca255f81/sdata201417-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/4322586/d5825f26cc4b/sdata201417-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c63/4322586/497c70899478/sdata201417-f3.jpg

相似文献

1
Genome-wide functional genomic and transcriptomic analyses for genes regulating sensitivity to vorinostat.全基因组功能基因组学和转录组学分析基因调控伏立诺他敏感性。
Sci Data. 2014 Jul 8;1:140017. doi: 10.1038/sdata.2014.17. eCollection 2014.
2
A genome scale RNAi screen identifies GLI1 as a novel gene regulating vorinostat sensitivity.一项全基因组规模的RNA干扰筛选将GLI1鉴定为调控伏立诺他敏感性的新基因。
Cell Death Differ. 2016 Jul;23(7):1209-18. doi: 10.1038/cdd.2015.175. Epub 2016 Feb 12.
3
Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput Genomics.利用高通量基因组学预测对组蛋白去乙酰化酶抑制剂的反应
J Natl Cancer Inst. 2015 Aug 21;107(11). doi: 10.1093/jnci/djv247. Print 2015 Nov.
4
Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model.组蛋白去乙酰化酶抑制剂在非小细胞肺癌细胞中的抗肿瘤活性:分子预测模型的建立
Mol Cancer Ther. 2008 Jul;7(7):1923-30. doi: 10.1158/1535-7163.MCT-07-2140. Epub 2008 Jul 7.
5
Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition.与组蛋白去乙酰化酶抑制作用导致前列腺癌细胞系放射增敏相关的缺氧非依赖性基因表达特征
Br J Cancer. 2016 Oct 11;115(8):929-939. doi: 10.1038/bjc.2016.278. Epub 2016 Sep 6.
6
Histone deacetylase inhibition restores cisplatin sensitivity of Hodgkin's lymphoma cells.组蛋白去乙酰化酶抑制恢复霍奇金淋巴瘤细胞对顺铂的敏感性。
Leuk Res. 2012 Jun;36(6):773-8. doi: 10.1016/j.leukres.2012.02.021. Epub 2012 Mar 17.
7
Targeting histone deacetylases: development of vorinostat for the treatment of cancer.靶向组蛋白去乙酰化酶:伏立诺他治疗癌症的研发。
Epigenomics. 2010 Jun;2(3):457-65. doi: 10.2217/epi.10.20.
8
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.组蛋白去乙酰化酶抑制剂伏立诺他通过调节表皮生长因子受体表达和逆转上皮间质转化增强吉非替尼治疗头颈部鳞状细胞癌的疗效。
J Cell Physiol. 2011 Sep;226(9):2378-90. doi: 10.1002/jcp.22574.
9
Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters.伏立诺他诱导套细胞淋巴瘤细胞凋亡是通过乙酰化促凋亡 BH3 仅蛋白基因启动子介导的。
Clin Cancer Res. 2011 Jun 15;17(12):3956-68. doi: 10.1158/1078-0432.CCR-10-3412. Epub 2011 Jun 7.
10
Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer.基因表达谱分析鉴定伏立诺他为胃癌的候选治疗药物。
PLoS One. 2011;6(9):e24662. doi: 10.1371/journal.pone.0024662. Epub 2011 Sep 9.

引用本文的文献

1
Genes regulating membrane-associated E-cadherin and proliferation in adenomatous polyposis coli mutant colon cancer cells: High content siRNA screen.调控腺瘤性结肠息肉病突变结肠癌细胞中膜相关 E-钙黏蛋白和增殖的基因:高内涵 siRNA 筛选。
PLoS One. 2020 Oct 15;15(10):e0240746. doi: 10.1371/journal.pone.0240746. eCollection 2020.
2
Genome-wide RNAi screen for genes regulating glycolytic response to vemurafenib in BRAF melanoma cells.全基因组 RNAi 筛选调控 BRAF 黑色素瘤细胞对 vemurafenib 糖酵解反应的基因。
Sci Data. 2020 Oct 12;7(1):339. doi: 10.1038/s41597-020-00683-z.
3
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes.

本文引用的文献

1
HTSeq--a Python framework to work with high-throughput sequencing data.HTSeq——一个用于处理高通量测序数据的Python框架。
Bioinformatics. 2015 Jan 15;31(2):166-9. doi: 10.1093/bioinformatics/btu638. Epub 2014 Sep 25.
2
A high-throughput, multiplex cell death assay using an RNAi screening approach.一种使用RNA干扰筛选方法的高通量、多重细胞死亡检测法。
Cold Spring Harb Protoc. 2014 Jun 2;2014(6):663-76. doi: 10.1101/pdb.prot080267.
3
voom: Precision weights unlock linear model analysis tools for RNA-seq read counts.voom:精确权重为RNA测序读数计数解锁线性模型分析工具。
莫塞替尼用于治疗既往治疗过的局部晚期/转移性尿路上皮癌和乙酰转移酶基因失活改变的患者。
Cancer. 2019 Feb 15;125(4):533-540. doi: 10.1002/cncr.31817. Epub 2018 Dec 20.
4
High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer.高通量 RNAi 筛选结直肠癌中的必需基因和药物协同组合。
Sci Data. 2017 Oct 3;4:170139. doi: 10.1038/sdata.2017.139.
5
Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy.地西他滨-伏立诺他联合治疗急性髓系白血病可激活具有新型三联疗法潜力的通路。
Oncotarget. 2017 May 19;8(31):51429-51446. doi: 10.18632/oncotarget.18009. eCollection 2017 Aug 1.
6
PubChem BioAssay: A Decade's Development toward Open High-Throughput Screening Data Sharing.PubChem 生物测定:迈向开放高通量筛选数据共享的十年发展。
SLAS Discov. 2017 Jul;22(6):655-666. doi: 10.1177/2472555216685069. Epub 2017 Jan 13.
7
Systematic high-content genome-wide RNAi screens of endothelial cell migration and morphology.内皮细胞迁移和形态的系统高内涵全基因组 RNAi 筛选
Sci Data. 2017 Mar 1;4:170009. doi: 10.1038/sdata.2017.9.
8
PubChem BioAssay: 2017 update.《PubChem生物测定:2017年更新》
Nucleic Acids Res. 2017 Jan 4;45(D1):D955-D963. doi: 10.1093/nar/gkw1118. Epub 2016 Nov 29.
9
Comprehensive analysis of high-throughput screens with HiTSeekR.使用HiTSeekR对高通量筛选进行综合分析。
Nucleic Acids Res. 2016 Aug 19;44(14):6639-48. doi: 10.1093/nar/gkw554. Epub 2016 Jun 21.
10
An interactive web-based application for Comprehensive Analysis of RNAi-screen Data.一个基于网络的用于RNA干扰筛选数据综合分析的交互式应用程序。
Nat Commun. 2016 Feb 23;7:10578. doi: 10.1038/ncomms10578.
Genome Biol. 2014 Feb 3;15(2):R29. doi: 10.1186/gb-2014-15-2-r29.
4
A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells.全基因组 siRNA 筛选鉴定蛋白酶体成瘾是基底样三阴性乳腺癌细胞的脆弱性。
Cancer Cell. 2013 Aug 12;24(2):182-96. doi: 10.1016/j.ccr.2013.07.008.
5
Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation.多形性胶质母细胞瘤中 polo 样激酶 1 的抑制诱导有丝分裂灾难并增强放射敏感性。
Eur J Cancer. 2013 Sep;49(14):3020-8. doi: 10.1016/j.ejca.2013.05.013. Epub 2013 Jun 18.
6
Depletion of RAD17 sensitizes pancreatic cancer cells to gemcitabine.RAD17 的耗竭使胰腺癌细胞对吉西他滨敏感。
J Cell Sci. 2013 Aug 1;126(Pt 15):3380-9. doi: 10.1242/jcs.124768. Epub 2013 May 17.
7
A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.一项针对乳腺癌基因组的靶向 RNAi 筛选发现,KIF14 和 TLN1 是调节三阴性乳腺癌多西他赛化疗敏感性的基因。
Clin Cancer Res. 2013 Apr 15;19(8):2061-70. doi: 10.1158/1078-0432.CCR-13-0082. Epub 2013 Mar 11.
8
A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells.一种合成相互作用筛选方法确定了 p53 缺陷型人类癌细胞增殖和 TERT 转录所需的选择性因子。
PLoS Genet. 2012;8(12):e1003151. doi: 10.1371/journal.pgen.1003151. Epub 2012 Dec 20.
9
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks.RNA-seq 实验中使用 TopHat 和 Cufflinks 的差异基因和转录本表达分析。
Nat Protoc. 2012 Mar 1;7(3):562-78. doi: 10.1038/nprot.2012.016.
10
A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response.全基因组同源重组筛选鉴定 RNA 结合蛋白 RBMX 为 DNA 损伤反应的一个组成部分。
Nat Cell Biol. 2012 Feb 19;14(3):318-28. doi: 10.1038/ncb2426.